SUN-413 Dual Endocrinopathies Following Single Dose of Pembrolizumab Therapy

Introduction: Immune related endocrine adverse effects (IReAs) caused by checkpoint inhibitors (CI) used in the treatment of advanced cancers are rare and often under recognized, but they can be potentially life-threatening. Case: A 69 y/o male with stage 4 metastatic colon cancer was evaluated 10 d...

Full description

Saved in:
Bibliographic Details
Published in:J Endocr Soc
Main Authors: Parikh, Tanvi, Sharma, Meeta
Format: Artigo
Language:Inglês
Published: Endocrine Society 2019
Subjects:
Neuroendocrinology and Pituitary
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6552853/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SUN-413
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items